Gastric DysmotilitySymptoms, Doctors, Treatments, Advances & More
Gastric Dysmotility Overview
Learn About Gastric Dysmotility
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Luis Gonzalez-Alcala practices practicing medicine in Barcelona, Spain. Mr. Gonzalez-Alcala is rated as an Elite expert by MediFind in the treatment of Gastric Dysmotility. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Gastric Dysmotility, Intestinal Pseudo-Obstruction, Systemic Sclerosis (SSc), Scleroderma, and Lung Transplant.
Temple University Hospital
Henry Parkman is a primary care provider, practicing in Internal Medicine in Philadelphia, Pennsylvania. He has been practicing medicine for over 44 years. Dr. Parkman is rated as an Elite provider by MediFind in the treatment of Gastric Dysmotility. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Gastroparesis, Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Endoscopy, and Lung Transplant. Dr. Parkman is currently accepting new patients.
University Of Louisville Physicians - Gastroenterology
Thomas Abell is a Gastroenterologist practicing medicine in Louisville, Kentucky. Dr. Abell is rated as an Elite provider by MediFind in the treatment of Gastric Dysmotility. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Gastroparesis, Gastric Dysmotility, Indigestion, Endoscopy, and Gastrectomy. Dr. Abell is board certified in American Board Of Internal Medicine, Gastroenterology - 1997 and American Board Of Internal Medicine, Internal Medicine - 1988. Dr. Abell is currently accepting new patients.
Summary: The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.